Credit Suisse’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $57.5M | Sell |
539,488
-312,544
| -37% | -$33.3M | 0.06% | 332 |
|
2023
Q4 | $84.7M | Sell |
852,032
-82,397
| -9% | -$8.19M | 0.08% | 236 |
|
2023
Q3 | $96.5M | Buy |
934,429
+150,932
| +19% | +$15.6M | 0.1% | 196 |
|
2023
Q2 | $95.2M | Buy |
783,497
+78,700
| +11% | +$9.56M | 0.09% | 214 |
|
2023
Q1 | $108M | Buy |
704,797
+121,742
| +21% | +$18.7M | 0.11% | 189 |
|
2022
Q4 | $105M | Sell |
583,055
-175,825
| -23% | -$31.6M | 0.11% | 188 |
|
2022
Q3 | $89.7M | Sell |
758,880
-164,227
| -18% | -$19.4M | 0.1% | 207 |
|
2022
Q2 | $132M | Buy |
923,107
+199,346
| +28% | +$28.5M | 0.14% | 152 |
|
2022
Q1 | $125M | Sell |
723,761
-151,341
| -17% | -$26.1M | 0.11% | 198 |
|
2021
Q4 | $222M | Sell |
875,102
-234,979
| -21% | -$59.7M | 0.12% | 112 |
|
2021
Q3 | $427M | Sell |
1,110,081
-100,211
| -8% | -$38.6M | 0.24% | 45 |
|
2021
Q2 | $284M | Sell |
1,210,292
-117,069
| -9% | -$27.5M | 0.15% | 92 |
|
2021
Q1 | $174M | Sell |
1,327,361
-398,619
| -23% | -$52.2M | 0.09% | 179 |
|
2020
Q4 | $180M | Buy |
1,725,980
+385,031
| +29% | +$40.2M | 0.09% | 152 |
|
2020
Q3 | $94.9M | Buy |
1,340,949
+80,382
| +6% | +$5.69M | 0.06% | 244 |
|
2020
Q2 | $80.9M | Sell |
1,260,567
-417,781
| -25% | -$26.8M | 0.06% | 269 |
|
2020
Q1 | $50.3M | Sell |
1,678,348
-1,205,563
| -42% | -$36.1M | 0.04% | 345 |
|
2019
Q4 | $56.4M | Buy |
2,883,911
+288,707
| +11% | +$5.65M | 0.04% | 367 |
|
2019
Q3 | $41.3M | Buy |
2,595,204
+491,879
| +23% | +$7.83M | 0.03% | 410 |
|
2019
Q2 | $30.8M | Buy |
2,103,325
+1,051,116
| +100% | +$15.4M | 0.03% | 535 |
|
2019
Q1 | $21.4M | Buy |
1,052,209
+452,209
| +75% | +$9.2M | 0.02% | 649 |
|
2018
Q4 | $9.16M | Buy |
+600,000
| New | +$9.16M | 0.01% | 965 |
|